Frontiers in Immunology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2023-06-02 ms6000000562901411 来自四川省

偏重的研究方向：生物信息学;肿瘤
经验分享：想请问一下生物信息学投这个杂志的文章类型是什么

75 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2024-02-29 ms9000000568355466 来自河南省

偏重的研究方向：结直肠癌
经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2024-03-05 ms5000001373452742 来自福建省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤免疫
经验分享：无语死了，都外审两天，突然收到邮件给拒了。

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2023-05-27 ms2000000510079560 来自布加勒斯特

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：炎症
经验分享：效率是真的高，服务是真的好，价格也是真的贵。
顺便问一句，大家担不担心被中科院预警，我很担心。。。

114 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2021-11-21 科研小王子66

审稿速度:3.0
偏重的研究方向：免疫;肿瘤免疫
经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？

132 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2022-09-07 ms5000001852951271

偏重的研究方向：biomarker
经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了

88 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2024-01-20 ms1000001045383040 来自山东省

返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2023-10-27 ms4000001836130031 来自吉林省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：综述
经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了

73 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2023-05-19 14853348m56暂无昵称来自上海

很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。

127 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191202, encodeId=60f221912026d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：无语死了，都外审两天，突然收到邮件给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Tue Mar 05 18:21:14 CST 2024, time=2024-03-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2139445, encodeId=5d0e213944515, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：效率是真的高，服务是真的好，价格也是真的贵。 顺便问一句，大家担不担心被中科院预警，我很担心。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7285412279, createdName=ms2000000510079560, createdTime=Sat May 27 23:09:37 CST 2023, time=2023-05-27, status=1, ipAttribution=布加勒斯特), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0 偏重的研究方向：免疫;肿瘤免疫 经验分享：Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247637, encodeId=e199124e63793, content=偏重的研究方向：biomarker 经验分享：请问在EA阶段，已经一周了，一直没有更新，显示review is ongoing，这个是百分百拒稿了么？百度结果好像是暗示拒稿，很慌，求大佬们解答，谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a00a8248803, createdName=ms5000001852951271, createdTime=Wed Sep 07 09:34:20 CST 2022, time=2022-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182917, encodeId=76dc218291eb4, content=返修提交之后没有收到邮件，请问大家返修提交上传后都不会收到邮件吗？不确定是否提交对地方，很茫然呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba98522524, createdName=ms1000001045383040, createdTime=Sat Jan 20 23:43:58 CST 2024, time=2024-01-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165204, encodeId=e9c02165204f8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：综述 经验分享：想请教下大家，10月9投，10.19第一个审稿人意见回来了，10.24编辑开放了论坛，但是只有一个审稿人意见，给了两周时间修改，这是什么意思呀？被拒的征兆吗？有点搞不懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=691d8767795, createdName=ms4000001836130031, createdTime=Fri Oct 27 10:12:18 CST 2023, time=2023-10-27, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2137866, encodeId=57ef213e86612, content=很有趣的杂志！之前审过一篇只有5个figure的文章，无论是工作量还是创新最多3分的水准。看在国人的面上提了一些意见给了大修，顺便把需要补的实验明细都附在了上面。过了两天修回来以后发现啥都没改，作者嘴硬的不行，于是我选择了reject。没想到editor把我这个审稿人拒了，这篇文章顺利以5张图online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fba5286246, createdName=14853348m56暂无昵称, createdTime=Fri May 19 13:21:36 CST 2023, time=2023-05-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163715, encodeId=495f2163e15ff, content=我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b55710624, createdName=ms6000001878152948, createdTime=Thu Oct 19 12:32:47 CST 2023, time=2023-10-19, status=1, ipAttribution=黑龙江省)]

2023-10-19 ms6000001878152948 来自黑龙江省

我得八天了，review finalized阶段一直没反应，两个审稿人同意发表，不知道还要等多久。

104 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务